Treosulfan, Fludarabine, and 2-Gy Total Body Irradiation Followed by Allogeneic Hematopoietic Cell Transplantation in Patients with Myelodysplastic Syndrome and Acute Myeloid LeukemiaBoglarka Gyurkocza, Hans Joachim Deeg, Jonathan A. Gutman et al.|Transplantation and Cellular Therapy|2014Cited by 58
Treosulfan–fludarabine–thiotepa-based conditioning treatment before allogeneic hematopoietic stem cell transplantation for pediatric patients with hematological malignanciesKrzysztof Kałwak, Ajay Vora, Paul G. Schlegel et al.|Bone Marrow Transplantation|2020Cited by 35
Prospective Phase II Multicenter Study of Conditioning with Treosulfan, Fludarabine and Low-Dose (2 Gy) Total Body Irradiation Followed by Hematopoietic Cell Transplantation From Related or Unrelated Donors for Acute Myeloid Leukemia and High-Risk Myelodysplastic SyndromeBoglarka Gyurkocza, H. Joachim Deeg, Jonathan A. Gutman et al.|Blood|2012Cited by 1
Bendamustin. Neue Wege bei Lymphomen und soliden Tumoren. Bendamustin-Workshop, Dresden, 2. September 2000T. Kühn, Christoph Kahl, R. Kreienberg et al.|Oncology Research and Treatment|2000Cited by 0
278: Treosulfan Plus Fludarabine for Allogeneic Hematopoietic Cell Transplantation (HCT) in Patients with Acute Leukemia and Myelodysplastic SyndromeEneida R. Nemecek, H. Joachim Deeg, B. Ly et al.|Transplantation and Cellular Therapy|2008Cited by 0